Patricia Rioja Viera

9PUBLICATIONS
77CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Midwifery not elsewhere classifiedMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 23, 2026
Breast Cancer-Protective Genetic Variant Common in Women of Indigenous American Genetic Ancestry Is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-Enriched Tumor Subtypes.

|May 13, 2026
Long-term survival with nivolumab in a patient with renal cell carcinoma: a case report and review of the literature.

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Jul 19, 2025
Primary Mediastinal Germ Cell Tumor With Bone Marrow Infiltration: A Case Report and Literature Review.

Patricia Rioja, Guillermo Valencia, Zaida Morante

|May 26, 2025
Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM).

|Dec 03, 2024
Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

Xiaosong Huang, Paul C Lott, Donglei Hu

Pageof 2

Frequent Collaborators

5 joint publications

Guillermo Valencia

5 joint publications

Silvia Patricia Neciosup

4 joint publications

Hugo Fuentes

4 joint publications

Zaida Morante